Literature DB >> 11531621

Risk for anogenital cancer and other cancer among women hospitalized with gonorrhea.

C Johansen1, L Mellemkjaer, M Frisch, S K Kjaer, G Gridley, J H Olsen.   

Abstract

BACKGROUND: We investigated the relationship between infections with Neisseria gonorrhoeae and anogenital and other cancers.
METHODS: Nationwide and population based register linkage study utilizing prospectively notified information. The observed numbers of cancers among the women were compared with those expected on the basis of national incidence rates.
RESULTS: In a cohort of 4440 women hospitalized for gonorrhea we observed a total of 227 cases of cervical intraepithelial neoplasia grade III (CIN III), with 103 expected (standardized incidence ratio (SIR), 2.2; 95% confidence interval (CI), 1.9-2.5). No significantly increased risk for other anogenital cancers or cancer at other sites was seen.
CONCLUSIONS: These results support the view that the observed association between gonorrheal infection and subsequent cervical preneoplasia is due mainly to surveillance bias. However, our results also indicate that women hospitalized with a N. gonorrhoeae infection will benefit from the compliance with the regular Pap smear screening programs.

Entities:  

Mesh:

Year:  2001        PMID: 11531621     DOI: 10.1034/j.1600-0412.2001.080008757.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral Therapy.

Authors:  Lois J Conley; Timothy J Bush; Teresa M Darragh; Joel M Palefsky; Elizabeth R Unger; Pragna Patel; Martin Steinau; E Milu Kojic; Harold Martin; E Turner Overton; Susan Cu-Uvin; John Hammer; Keith Henry; Kathleen Wood; John T Brooks
Journal:  J Infect Dis       Date:  2015-08-12       Impact factor: 5.226

2.  Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.

Authors:  Shirish Shukla; Gauri Shishodia; Sutapa Mahata; Suresh Hedau; Arvind Pandey; Suresh Bhambhani; Swaraj Batra; Seemi F Basir; Bhudev C Das; Alok C Bharti
Journal:  Mol Cancer       Date:  2010-10-27       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.